Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA Announces Strategic Partnership with Acceleron to Advance CMT Treatment Options
…developing medicines to treat serious and rare diseases, including CMT. The CMTA’s Strategy to Accelerate Research (STAR) connects top CMT clinicians and academic researchers with pharmaceutical partners committed to developing…
Seattle Focus Group with Acceleron Pharma
We are pleased to announce another opportunity to get involved with the CMTA’s Patients as Partners in Research initiative! The goal of Patients as Partners in Research is to advance…
CMTA’s $240K Investment Targets Gene Replacement Therapy in CMT4 Subtypes
…the Strategy to Accelerate Research (STAR) initiative, CMTA has been at the forefront of accelerating gene replacement therapies for CMT, underscoring our leadership in this critical area of research,” said…
Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success
…stay current on this and all other CMT research and CMTA news. Create Your Patients as Partners in Research Profile Sign up for CMTA eNews Published On: October 29, 2024…
Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C
…as they move this program forward for people living with CMT2C. Get Involved in CMT Research Not yet registered with Patients as Partners in Research? By registering, you’ll be among…
Statement from CMTA’s Chief Executive Officer, Sue Bruhn, PhD
…rare diseases, federal support for biomedical research and stability at national public health agencies are essential to advancing lifesaving programs and public health initiatives. Through CMTA’s Strategy To Accelerate Research…
CMTAWinter2021Report
For Researchers & Industry
CMTA and ToolGen Announce CMT1A Collaboration
…CMTA has been able to establish research partnerships with almost 40 pharmaceutical and biotech companies, and leading research labs around the world.” The testing alliance with ToolGen involves access to…
CMTA Announces New Center of Excellence at Virginia Commonwealth University
…FAAN, Director of the Center for Inherited Myology Research (CIMR), Professor, and Vice Chair of Research in Neurology at VCU. Dr. Johnson is a distinguished neuromuscular specialist with a robust…